You will be a winner to those who took your recommendation.
I think we will see the next update as another trial update confirming the products outstanding results as consistent with initial results.
This won't be new to us but it will grab the markets attention again and drive the price. The key here is this product will detect early signs of PAD (Peripheral artery disease ) and PVD (Peripheral vascular disease).
Currently there are NO early detection for these life threatening conditions and the test that DOES detect these conditions are not recommended until the signs of the conditions appear due to it is not deemed as medically necessary until those symptoms appear. Due to the cost of these test Medicare does not approve them until symptoms warrant them as medically necessary either. Unfortunately by then it is too late and the resulting conditions runs in the hundreds of thousands in cost to treat. Stints, bypasses, etc ALL OVER THE BODY! This is going to save money for the insurance companies (consumer will win with lower premiums from lower claims) and Medicare but most importantly will SAVE LIVES by not only detecting the earliest signs of PVD/PAD but detecting those who are most likely to develop PVD & PAD as well. Cholesterol medication & high cholesterol treatments will soar from from the implementation of this product as well. FYI
News 
Market Data 
Discover 
